Alkem Laboratories Limited — Call Transcript 2026

Feb 13, 2026

==> picture [595 x 115] intentionally omitted <==

13[th] February, 2026

To,
The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001. Scrip Code: 539523	National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai 400 051. Scrip Symbol: ALKEM

Sub: Revised intimation of Conference Call on Q3FY26 and 9MFY26 financial results – Change in Conference Call Participants

Dear Sir(s) / Madam,

This is in furtherance to our earlier intimations dated 23[rd] January, 2026 and 12[th] February, 2026 with regard to conference call to discuss the Q3FY26 and 9MFY26 financial results to held on Friday, February 13, 2026 at 5:00 pm.

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that there is change in conference call Participants to discuss the Q3FY26 and 9MFY26 financial results on Friday, February 13, 2026 at 5.00 p.m.

Please find attached herewith the updated conference call details.

Kindly take note of the same.

Sincerely,

For Alkem Laboratories Limited

MANISH Digitally signed by MANISH NARANG NARANG Date: 2026.02.13 14:03:26 +05'30'

Manish Narang

President – Legal, Company Secretary & Compliance Officer

==> picture [110 x 71] intentionally omitted <==

==> picture [15 x 10] intentionally omitted <==

==> picture [34 x 10] intentionally omitted <==

==> picture [34 x 10] intentionally omitted <==

==> picture [33 x 9] intentionally omitted <==

==> picture [10 x 9] intentionally omitted <==

==> picture [8 x 9] intentionally omitted <==

==> picture [9 x 9] intentionally omitted <==

==> picture [220 x 31] intentionally omitted <==

==> picture [128 x 19] intentionally omitted <==

==> picture [120 x 7] intentionally omitted <==

– Revised Intimation Change in Conference Call Participants

Invite for Q3FY26 & 9MFY26 Conference Call at 5.00 pm IST, February 13, 2026

Mumbai, February 13, 2026: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Friday, February 13, 2026, from 5:00 pm to 6:00 pm IST to discuss its Q3 and 9MFY26 financial results. The call will follow the announcement of the Company’s Q3 and 9MFY26 financial results on Friday, February 13, 2026.

Alkem Laboratories Ltd. will be represented on the call by:

Mr. Sandeep Singh - MD

Dr. Vikas Gupta – CEO, Alkem Laboratories

Mr. Nitin Agrawal – CFO

Mr. Kaustav Banerjee – CEO, Alkem MedTech

Motilal Oswal Securities Ltd. will host the call. Details of the

conference call are as follows Time 5:00 pm IST (GMT + 5:30) on Friday, February 13, 2026.

Dial in Details

India +91 22 6280 1149 / +91 22 7115 8050

International Toll-Free

==> picture [502 x 130] intentionally omitted <==

----- Start of picture text -----

USA 1 866 746 2133 UK 0 808 101 1573
Singapore 800 101 2045 Hong Kong 800 964 448
Express Join with Diamond Pass
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5695698&link
SecurityString=2d7a78d3cc
----- End of picture text -----

You are requested to dial in 10 minutes ahead of the scheduled start time.

Purvi Shah / Isha Trivedi

isha.trivedi@alkem.com

Investor Relations / Media Alkem Laboratories Ltd. Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: purvi.shah@alkem.com/

Tushar Manudhane

Institutional Research Analyst - Healthcare Motilal Oswal Securities Ltd. Tel.: +91 22 6129 1536 / +91 82911 38039 E-mail: Tushar.Manudhane@motilaloswal.com